神経精神障害&治療の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21APR4097)
◆英語タイトル:Global Neuropsychiatric Disorders and Treatment Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR4097
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年4月
◆ページ数:97
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥526,500見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥789,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、神経精神障害&治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(薬物治療、ショック治療、その他)、用途別市場規模(病院、診療所、研究センター)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・神経精神障害&治療の市場動向
・企業の競争状況、市場シェア
・神経精神障害&治療の種類別市場規模(薬物治療、ショック治療、その他)
・神経精神障害&治療の用途別市場規模(病院、診療所、研究センター)
・神経精神障害&治療の北米市場規模2016-2027(アメリカ、カナダ)
・神経精神障害&治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・神経精神障害&治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・神経精神障害&治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・神経精神障害&治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Astrazeneca、Glaxosmithkline、Universal Health Services、Boehringer Ingelheim、Eli Lilly)
・結論
【レポートの概要】

Neuropsychiatric disorder is a blanket medical term that encompasses a broad range of medical conditions that involve both neurology and psychiatry. Common neuropsychiatric disorders include seizures, attention deficits, cognitive deficits, palsies, uncontrolled anger, migraine headaches, addictions, eating disorders, depression, and anxiety and others. They can range widely in cause, course, and severity.
The key component of neuropsychiatric disorders is that the symptoms tend to impact brain function, emotion and mood. These can range from problems with focus and learning in the case of ADHD to sadness, irritability, memory problems, mood problems, depression to a variety of other psychiatric and/or neurological symptoms. Medications, psychological and/or psychiatric therapy are common treatments for neuropsychiatric disorders. Specific treatments will vary based on the precise cause, clinical presentation and severity.

Market Analysis and Insights: Global Neuropsychiatric Disorders and Treatment Market
The global Neuropsychiatric Disorders and Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Neuropsychiatric Disorders and Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Neuropsychiatric Disorders and Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Neuropsychiatric Disorders and Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Neuropsychiatric Disorders and Treatment market.

Global Neuropsychiatric Disorders and Treatment Scope and Market Size
Neuropsychiatric Disorders and Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Neuropsychiatric Disorders and Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Drug Treatment
Shock Treatment
Others

Segment by Application
Hospitals
Clinics
Research Centres

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Astrazeneca
Glaxosmithkline
Universal Health Services
Boehringer Ingelheim
Eli Lilly

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuropsychiatric Disorders and Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Drug Treatment
1.2.3 Shock Treatment
1.2.4 Others
1.3 Market by Application
1.3.1 Global Neuropsychiatric Disorders and Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Centres
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Neuropsychiatric Disorders and Treatment Market Perspective (2016-2027)
2.2 Neuropsychiatric Disorders and Treatment Growth Trends by Regions
2.2.1 Neuropsychiatric Disorders and Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Neuropsychiatric Disorders and Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Neuropsychiatric Disorders and Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Neuropsychiatric Disorders and Treatment Industry Dynamic
2.3.1 Neuropsychiatric Disorders and Treatment Market Trends
2.3.2 Neuropsychiatric Disorders and Treatment Market Drivers
2.3.3 Neuropsychiatric Disorders and Treatment Market Challenges
2.3.4 Neuropsychiatric Disorders and Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Neuropsychiatric Disorders and Treatment Players by Revenue
3.1.1 Global Top Neuropsychiatric Disorders and Treatment Players by Revenue (2016-2021)
3.1.2 Global Neuropsychiatric Disorders and Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Neuropsychiatric Disorders and Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Neuropsychiatric Disorders and Treatment Revenue
3.4 Global Neuropsychiatric Disorders and Treatment Market Concentration Ratio
3.4.1 Global Neuropsychiatric Disorders and Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuropsychiatric Disorders and Treatment Revenue in 2020
3.5 Neuropsychiatric Disorders and Treatment Key Players Head office and Area Served
3.6 Key Players Neuropsychiatric Disorders and Treatment Product Solution and Service
3.7 Date of Enter into Neuropsychiatric Disorders and Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Neuropsychiatric Disorders and Treatment Breakdown Data by Type
4.1 Global Neuropsychiatric Disorders and Treatment Historic Market Size by Type (2016-2021)
4.2 Global Neuropsychiatric Disorders and Treatment Forecasted Market Size by Type (2022-2027)

5 Neuropsychiatric Disorders and Treatment Breakdown Data by Application
5.1 Global Neuropsychiatric Disorders and Treatment Historic Market Size by Application (2016-2021)
5.2 Global Neuropsychiatric Disorders and Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Neuropsychiatric Disorders and Treatment Market Size (2016-2027)
6.2 North America Neuropsychiatric Disorders and Treatment Market Size by Type
6.2.1 North America Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2021)
6.2.2 North America Neuropsychiatric Disorders and Treatment Market Size by Type (2022-2027)
6.2.3 North America Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2027)
6.3 North America Neuropsychiatric Disorders and Treatment Market Size by Application
6.3.1 North America Neuropsychiatric Disorders and Treatment Market Size by Application (2016-2021)
6.3.2 North America Neuropsychiatric Disorders and Treatment Market Size by Application (2022-2027)
6.3.3 North America Neuropsychiatric Disorders and Treatment Market Size by Application (2016-2027)
6.4 North America Neuropsychiatric Disorders and Treatment Market Size by Country
6.4.1 North America Neuropsychiatric Disorders and Treatment Market Size by Country (2016-2021)
6.4.2 North America Neuropsychiatric Disorders and Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Neuropsychiatric Disorders and Treatment Market Size (2016-2027)
7.2 Europe Neuropsychiatric Disorders and Treatment Market Size by Type
7.2.1 Europe Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2021)
7.2.2 Europe Neuropsychiatric Disorders and Treatment Market Size by Type (2022-2027)
7.2.3 Europe Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2027)
7.3 Europe Neuropsychiatric Disorders and Treatment Market Size by Application
7.3.1 Europe Neuropsychiatric Disorders and Treatment Market Size by Application (2016-2021)
7.3.2 Europe Neuropsychiatric Disorders and Treatment Market Size by Application (2022-2027)
7.3.3 Europe Neuropsychiatric Disorders and Treatment Market Size by Application (2016-2027)
7.4 Europe Neuropsychiatric Disorders and Treatment Market Size by Country
7.4.1 Europe Neuropsychiatric Disorders and Treatment Market Size by Country (2016-2021)
7.4.2 Europe Neuropsychiatric Disorders and Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size (2016-2027)
8.2 Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Type
8.2.1 Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Application
8.3.1 Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Region
8.4.1 Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Neuropsychiatric Disorders and Treatment Market Size (2016-2027)
9.2 Latin America Neuropsychiatric Disorders and Treatment Market Size by Type
9.2.1 Latin America Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Neuropsychiatric Disorders and Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2027)
9.3 Latin America Neuropsychiatric Disorders and Treatment Market Size by Application
9.3.1 Latin America Neuropsychiatric Disorders and Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Neuropsychiatric Disorders and Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Neuropsychiatric Disorders and Treatment Market Size by Application (2016-2027)
9.4 Latin America Neuropsychiatric Disorders and Treatment Market Size by Country
9.4.1 Latin America Neuropsychiatric Disorders and Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Neuropsychiatric Disorders and Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size (2016-2027)
10.2 Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Type
10.2.1 Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Application
10.3.1 Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Country
10.4.1 Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Astrazeneca
11.1.1 Astrazeneca Company Details
11.1.2 Astrazeneca Business Overview
11.1.3 Astrazeneca Neuropsychiatric Disorders and Treatment Introduction
11.1.4 Astrazeneca Revenue in Neuropsychiatric Disorders and Treatment Business (2016-2021)
11.1.5 Astrazeneca Recent Development
11.2 Glaxosmithkline
11.2.1 Glaxosmithkline Company Details
11.2.2 Glaxosmithkline Business Overview
11.2.3 Glaxosmithkline Neuropsychiatric Disorders and Treatment Introduction
11.2.4 Glaxosmithkline Revenue in Neuropsychiatric Disorders and Treatment Business (2016-2021)
11.2.5 Glaxosmithkline Recent Development
11.3 Universal Health Services
11.3.1 Universal Health Services Company Details
11.3.2 Universal Health Services Business Overview
11.3.3 Universal Health Services Neuropsychiatric Disorders and Treatment Introduction
11.3.4 Universal Health Services Revenue in Neuropsychiatric Disorders and Treatment Business (2016-2021)
11.3.5 Universal Health Services Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Details
11.4.2 Boehringer Ingelheim Business Overview
11.4.3 Boehringer Ingelheim Neuropsychiatric Disorders and Treatment Introduction
11.4.4 Boehringer Ingelheim Revenue in Neuropsychiatric Disorders and Treatment Business (2016-2021)
11.4.5 Boehringer Ingelheim Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Details
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Neuropsychiatric Disorders and Treatment Introduction
11.5.4 Eli Lilly Revenue in Neuropsychiatric Disorders and Treatment Business (2016-2021)
11.5.5 Eli Lilly Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 神経精神障害&治療の世界市場規模・現状・予測2021年-2027年(Global Neuropsychiatric Disorders and Treatment Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。